Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: A Pediatric Oncology Group study

Cancer

Volumn 88, Issue 5, 2000, Pages 1166-1174

  Buchanan, George R ^a,i   Rivera, Gaston K ^b   Pollock, Brad H ^c,d   Boyett, James M ^b,c   Chauvenet, Allen R ^e   Wagner, Hans ^f   Maybee, David A ^g   Crist, William M ^b   Pinkel, Donald ^h  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d Pediat Oncol Grp Stat Office   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f Swiss Pediatric Oncology Group   (Switzerland)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ Pediat Oncol Grp Operations Off   (United States)

Author keywords

Acute leukemia; Bone marrow transplantation; Chemotherapy; Lymphoid; Relapse

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; HYDROCORTISONE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLERGIC REACTION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW SUPPRESSION; CHEMOTHERAPY; CHILD; CONTROLLED STUDY; FEMALE; FEVER; HEMORRHAGIC PANCREATITIS; HUMAN; INFANT; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; SEPTICEMIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BONE MARROW TRANSPLANTATION; CHILD; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; PREDNISONE; RECURRENCE; REMISSION INDUCTION; TENIPOSIDE; VINCRISTINE;

EID: 0034163292     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1166::AID-CNCR29>3.0.CO;2-W     Document Type: Article

References (39)

1. Buchanan GR, Rivera GK, Boyett JM, Chauvenet A, Crist W, Vietti T. Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group study. Blood 1988;72:1286-92.
2. Culbert SJ, Shuster JJ, Land VJ, Wharam MD, Thomas PRM, Nitschke R, et al. Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study. Cancer 1991; 67:37-42.
3. Musgrave S, Dickerman JD, Land VJ. Second or subsequent remission with a disease-free survival of 5 years or longer in acute lymphocytic leukemia of childhood: results of a national survey. Pediatrics 1986;77:765-9.
4. Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM Group. Blood 1991;78:1166-72.
5. Chessells JM, Leiper AD, Richards SM. A second course of treatment of childhood acute lymphoblastic leukaemia: long-term follow-up is needed to assess results. Br J Haematol 1994;86:48-54.
6. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia: 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med 1993;329:1289-95.
7. Rivera GK, Buchanan G, Boyett M, Camitta B, Ochs J, Kalwinsky D, et al. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group study. N Engl J Med 1986;315:273-8.
8. Sanders JE, Thomas ED, Buckner CD, Doney K. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 1987;760:324-6.
9. Kersey JH, Weisdorf D, Nesbit ME, LeBien TW, Woods WG. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 1987;317:461-7.
10. Chessells JM. Relapsed lymphoblastic leukaemia in children: a continuing challenge. Br J Haematol 1998;102:423-38.
11. Crist W, Boyett J, Jackson J, Vietta T, Borowitz A. Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1989;74:1252-9.
12. Sadowitz D, Smith SD, Shuster J, Wharam MD, Buchanan GR, Rivera GK. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1993;81:602-9.
13. Winick N, Buchanan GR, Murphy SB, Yu A, Boyett J. Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: a Pediatric Oncology Group study. Med Pediatr Oncol 1988;16:327-32.
14. Mullen CA, Buchanan GR. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low risk patient. J Clin Oncol 1990;8:1998-2004.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
16. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-38.
17. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A 1972;135:185-220.
18. Cox DR. Regression models and lifetables (with discussion). J R Stat Soc B 1972;34:1987-2200.
19. Harrel FE, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modeling strategies for improved prognostic predictions. Stat Med 1984;3:143-52.
20. Dixon WJ, Brown MB, Engelman L, Hill MA, Jennrich RI. BMDP Statistical Software. Volume 2. Berkeley: University of California Press, 1988.
21. Chauvenet AR, Smith NM. Referral of pediatric oncology patients for marrow transplantation and the process of informed consent. Med Pediatr Oncol 1988;16:40-4.
22. Durbin M. Bone marrow transplantation: economic, ethical, and social issues. Pediatrics 1988;82:774-83.
23. Pinkel D. Bone marrow transplantation in children. J Pediatr 1993;122:331-41.
24. Rivera GK, Hudson MM, Liu Q, Benamin E, Ribeiro RC, et al. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia. Blood 1996;88:831-7.
25. Schroeder H, Garwicz S, Kristinsson J, Siimes MA, Wesenberg F, et al. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Med Pediatr Oncol 1995;25: 372-8.
26. Torres A, Martinez F, Gomez P, Fornes G, Rojas R, Herrera C, et al. Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission. Bone Marrow Transplant 1989;4:609-12.
27. Dopfer R, Henze G, Bender-Gotze C, Ebell W, Ehninger G, Friedrich W, et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM-and CoAll-protocols: results of the German Cooperative study. Blood 1991;78:2780-4.
28. Wheeler K, Chessells JM, Bailey CC, Richards S. MRC UKALL X: treatment and outcome of patients after first relapse in acute lymphoblastic leukaemia [Abstract P-23]. Med Pediatr Oncol 1994;23:195.
29. Schmid H, Linderkamp C, Hartmann R, Fengler R, Henze G. Allogeneic BMT is superior to chemotherapy in early relapsed childhood ALL: results of four consecutive ALL-REZ BFM studies [Abstract P-57]. Med Pediatr Oncol 1994;23:203.
30. Barrett AJ, Horowitz MM, Pollock BH, Zhang M-J, Bortin MM, Cuahanan GR, et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994;331:1253-8.
31. Weisdorf DJ, Billett AL, Hannan P, Ritz J, Sallan SE, et al. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood 1997;90:1962-8.
32. Borgmann A, Schmid H, Hartmann R, Baumgarten E, Hermann K, et al. Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. Lancet 1995;346:873-6.
33. Graham-Pole J. Treating acute lymphoblastic leukaemia after relapse: bone marrow transplantation or not? Lancet 1989;2:1517-8.
34. Viana MB, Murao M, Ramos G, Oliveira HM, de Carvalho RI, de Bastos M, et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child 1994;71:304-10.
35. Pinkel D. Ethnicity and survival in children with acute lymphoid leukemia. Leukemia 1993;7:146-7.
36. Klingemann H-G, Deeg HJ, Self ED, Storb T, Storb R. Is race a risk factor for allogeneic marrow transplantation. Bone Marrow Transplant 1986;1:87-94.
37. Buchanan GR, Boyett JM, Pollock BH, Smith SD, Yanofsky R, Ghim T, et al. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. Cancer 1991;68:48-55.
38. Wofford MM, Smith SD, Shuster JJ, Johnson W, Buchanan GR, Wharam MD, et al. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1992; 10:624-30.
39. Winick NJ, Smith SD, Shuster J, Lauer S, Wharam MD, Land V, et al. Treatment of CNS relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1993;11:271-8.